| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | keratinization | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A SPRR2D SPRR2F LCE3A LCE1F LCE4A LCE3E LCE3C LCE5A | 2.13e-29 | 87 | 21 | 14 | GO:0031424 |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A SPRR2D SPRR2F LCE3A LCE1F LCE4A LCE3E LCE3C LCE5A | 1.98e-24 | 189 | 21 | 14 | GO:0030216 |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A SPRR2D SPRR2F LCE3A LCE1F LCE4A LCE3E LCE3C LCE5A | 6.81e-22 | 284 | 21 | 14 | GO:0009913 |
| GeneOntologyBiologicalProcess | skin development | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A SPRR2D SPRR2F LCE3A LCE1F LCE4A LCE3E LCE3C LCE5A | 3.25e-20 | 373 | 21 | 14 | GO:0043588 |
| GeneOntologyBiologicalProcess | epidermis development | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A SPRR2D SPRR2F LCE3A LCE1F LCE4A LCE3E LCE3C LCE5A | 6.44e-19 | 461 | 21 | 14 | GO:0008544 |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A SPRR2D SPRR2F LCE3A LCE1F LCE4A LCE3E LCE3C LCE5A | 4.50e-15 | 870 | 21 | 14 | GO:0030855 |
| GeneOntologyBiologicalProcess | epithelium development | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A SPRR2D SPRR2F LCE3A LCE1F LCE4A LCE3E LCE3C LCE5A CSMD1 | 2.07e-13 | 1469 | 21 | 15 | GO:0060429 |
| GeneOntologyCellularComponent | cornified envelope | 1.52e-05 | 69 | 15 | 3 | GO:0001533 | |
| MousePheno | increased total body fat amount | 1.84e-06 | 424 | 14 | 6 | MP:0010024 | |
| MousePheno | decreased bone mineral content | 3.14e-06 | 465 | 14 | 6 | MP:0010124 | |
| MousePheno | abnormal bone mineral content | 3.64e-05 | 713 | 14 | 6 | MP:0010122 | |
| MousePheno | abnormal adipose tissue amount | 3.61e-04 | 1077 | 14 | 6 | MP:0005452 | |
| MousePheno | abnormal adipose tissue morphology | 1.27e-03 | 1361 | 14 | 6 | MP:0000003 | |
| MousePheno | abnormal bone structure | 1.36e-03 | 1379 | 14 | 6 | MP:0003795 | |
| MousePheno | adipose tissue phenotype | 1.38e-03 | 1383 | 14 | 6 | MP:0005375 | |
| Domain | SPRR/LCE | LCE1C LCE1B LCE1E LCE1D LCE1A SPRR2D SPRR2F LCE3A LCE1F LELP1 LCE4A LCE3E LCE3C LCE5A | 1.78e-36 | 28 | 22 | 14 | IPR026075 |
| Domain | LCE | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A LCE3A LCE1F LCE4A LCE3E LCE3C LCE5A | 1.06e-33 | 17 | 22 | 12 | PF14672 |
| Domain | LCE | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A LCE3A LCE1F LCE4A LCE3E LCE3C LCE5A | 1.06e-33 | 17 | 22 | 12 | IPR028205 |
| Domain | SPRR2 | 1.98e-05 | 6 | 22 | 2 | IPR029142 | |
| Domain | SPRR2 | 1.98e-05 | 6 | 22 | 2 | PF14820 | |
| Domain | SH2 | 6.23e-03 | 101 | 22 | 2 | PF00017 | |
| Domain | SH2 | 7.35e-03 | 110 | 22 | 2 | SM00252 | |
| Domain | SH2 | 7.48e-03 | 111 | 22 | 2 | PS50001 | |
| Domain | SH2 | 7.61e-03 | 112 | 22 | 2 | IPR000980 | |
| Domain | - | 7.61e-03 | 112 | 22 | 2 | 3.30.505.10 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A SPRR2D SPRR2F LCE3A LCE1F LELP1 LCE4A LCE3E LCE3C LCE5A | 1.70e-27 | 129 | 20 | 15 | M27649 |
| Pathway | REACTOME_KERATINIZATION | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A SPRR2D SPRR2F LCE3A LCE1F LELP1 LCE4A LCE3E LCE3C LCE5A | 5.74e-24 | 217 | 20 | 15 | M27640 |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A SPRR2D SPRR2F LCE3A VAV3 LCE1F LGI3 LELP1 LCE4A LCE3E LCE3C LCE5A | 1.01e-14 | 1432 | 20 | 17 | M509 |
| Pathway | PID_CDC42_REG_PATHWAY | 8.12e-04 | 30 | 20 | 2 | M83 | |
| Pubmed | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A LCE3A LCE1F LCE4A LCE3E LCE3C LCE5A | 6.39e-35 | 22 | 22 | 12 | 15854049 | |
| Pubmed | Differentially expressed late constituents of the epidermal cornified envelope. | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A LCE3A LCE1F LCE4A LCE3E LCE3C LCE5A | 1.34e-34 | 23 | 22 | 12 | 11698679 |
| Pubmed | 2.77e-26 | 16 | 22 | 9 | 17410201 | ||
| Pubmed | The DNA sequence and biological annotation of human chromosome 1. | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A SPRR2D SPRR2F LCE3A LCE1F LELP1 LCE4A BCAR3 LCE3E LCE3C LCE5A | 2.00e-20 | 1031 | 22 | 16 | 16710414 |
| Pubmed | Assessment of community efforts to advance network-based prediction of protein-protein interactions. | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A LCE3A LCE1F LELP1 LCE4A LCE3E LCE3C LCE5A | 8.57e-18 | 630 | 22 | 13 | 36949045 |
| Pubmed | CYSRT1: An Antimicrobial Epidermal Protein that Can Interact with Late Cornified Envelope Proteins. | 1.30e-15 | 7 | 22 | 5 | 36804407 | |
| Pubmed | 1.20e-13 | 4 | 22 | 4 | 29397434 | ||
| Pubmed | 8.78e-10 | 4 | 22 | 3 | 11350120 | ||
| Pubmed | 2.19e-09 | 5 | 22 | 3 | 11159194 | ||
| Pubmed | Fate and plasticity of the epidermis in response to congenital activation of BRAF. | 6.26e-08 | 13 | 22 | 3 | 25202828 | |
| Pubmed | 6.54e-08 | 62 | 22 | 4 | 26644517 | ||
| Pubmed | 1.22e-07 | 16 | 22 | 3 | 21930775 | ||
| Pubmed | 5.01e-07 | 25 | 22 | 3 | 23132931 | ||
| Pubmed | Insulin/IGF-1 controls epidermal morphogenesis via regulation of FoxO-mediated p63 inhibition. | 5.01e-07 | 25 | 22 | 3 | 23906066 | |
| Pubmed | 5.66e-07 | 26 | 22 | 3 | 15454262 | ||
| Pubmed | 9.76e-07 | 31 | 22 | 3 | 20930145 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 19169255 | ||
| Pubmed | Psoriasis-Associated Late Cornified Envelope (LCE) Proteins Have Antibacterial Activity. | 1.15e-06 | 3 | 22 | 2 | 28634035 | |
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 27048876 | ||
| Pubmed | 9.90e-06 | 832 | 22 | 6 | 36724073 | ||
| Pubmed | Estrogen regulates the expression of the small proline-rich 2 gene family in the mouse uterus. | 1.07e-05 | 8 | 22 | 2 | 15232223 | |
| Pubmed | 1.37e-05 | 9 | 22 | 2 | 11279051 | ||
| Pubmed | 1.71e-05 | 10 | 22 | 2 | 8325635 | ||
| Pubmed | 2.51e-05 | 12 | 22 | 2 | 18643845 | ||
| Pubmed | 2.51e-05 | 12 | 22 | 2 | 9888996 | ||
| Pubmed | 3.99e-05 | 15 | 22 | 2 | 18316326 | ||
| Pubmed | Variation in genes of the epidermal differentiation complex in German atopic dermatitis patients. | 7.96e-05 | 21 | 22 | 2 | 19601998 | |
| Interaction | KRTAP5-2 interactions | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A LCE3A LCE1F LELP1 LCE4A LCE3E LCE3C LCE5A | 2.80e-28 | 62 | 22 | 13 | int:KRTAP5-2 |
| Interaction | KRTAP5-4 interactions | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A LCE3A LCE1F LELP1 LCE4A LCE3E LCE3C LCE5A | 3.52e-28 | 63 | 22 | 13 | int:KRTAP5-4 |
| Interaction | KRTAP5-11 interactions | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A LCE3A LCE1F LELP1 LCE4A LCE3E LCE3C LCE5A | 6.88e-28 | 66 | 22 | 13 | int:KRTAP5-11 |
| Interaction | KRTAP5-3 interactions | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A LCE3A LCE1F LELP1 LCE4A LCE3E LCE3C LCE5A | 6.88e-28 | 66 | 22 | 13 | int:KRTAP5-3 |
| Interaction | KRTAP4-5 interactions | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A LCE3A LCE1F LELP1 LCE4A LCE3E LCE3C LCE5A | 5.11e-27 | 76 | 22 | 13 | int:KRTAP4-5 |
| Interaction | KRTAP4-11 interactions | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A LCE3A LCE1F LELP1 LCE4A LCE3E LCE3C LCE5A | 7.43e-26 | 92 | 22 | 13 | int:KRTAP4-11 |
| Interaction | KRTAP5-6 interactions | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A LCE3A LCE1F LELP1 LCE4A LCE3E LCE3C LCE5A | 1.00e-25 | 94 | 22 | 13 | int:KRTAP5-6 |
| Interaction | KRTAP10-11 interactions | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A LCE3A LCE1F LCE4A LCE3E LCE3C LCE5A | 2.22e-25 | 64 | 22 | 12 | int:KRTAP10-11 |
| Interaction | RGS17 interactions | LCE3D LCE1B LCE1E LCE1D LCE1A LCE3A LCE1F LCE4A LCE3E LCE3C LCE5A | 2.81e-24 | 48 | 22 | 11 | int:RGS17 |
| Interaction | KRTAP4-4 interactions | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A LCE3A LCE1F LCE4A LCE3E LCE3C LCE5A | 4.74e-24 | 81 | 22 | 12 | int:KRTAP4-4 |
| Interaction | KRTAP9-2 interactions | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A LCE3A LCE1F LELP1 LCE4A LCE3E LCE3C LCE5A | 5.43e-23 | 149 | 22 | 13 | int:KRTAP9-2 |
| Interaction | KRTAP9-8 interactions | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A LCE3A LCE1F LCE4A LCE3E LCE3C LCE5A | 6.98e-23 | 100 | 22 | 12 | int:KRTAP9-8 |
| Interaction | KRTAP10-5 interactions | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A LCE3A LCE1F LELP1 LCE4A LCE3E LCE3C LCE5A | 1.42e-22 | 160 | 22 | 13 | int:KRTAP10-5 |
| Interaction | KRTAP4-12 interactions | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A LCE3A LCE1F LELP1 LCE4A LCE3E LCE3C LCE5A | 1.54e-22 | 161 | 22 | 13 | int:KRTAP4-12 |
| Interaction | SPRY1 interactions | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A LCE3A LCE1F LCE4A LCE3E LCE3C LCE5A | 2.61e-22 | 111 | 22 | 12 | int:SPRY1 |
| Interaction | LCE2D interactions | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A LCE3A LCE1F LCE4A LCE3C LCE5A | 5.13e-22 | 74 | 22 | 11 | int:LCE2D |
| Interaction | ALPP interactions | LCE1C LCE3D LCE1B LCE1E LCE1D LCE3A LCE1F LELP1 LCE4A LCE3E LCE3C LCE5A | 9.46e-22 | 123 | 22 | 12 | int:ALPP |
| Interaction | KRTAP1-5 interactions | 1.36e-21 | 48 | 22 | 10 | int:KRTAP1-5 | |
| Interaction | LCE2B interactions | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A LCE3A LCE1F LCE4A LCE3C LCE5A | 1.48e-21 | 81 | 22 | 11 | int:LCE2B |
| Interaction | KRTAP4-2 interactions | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A LCE3A LCE1F LCE4A LCE3E LCE3C LCE5A | 2.29e-21 | 132 | 22 | 12 | int:KRTAP4-2 |
| Interaction | KRTAP5-9 interactions | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A LCE3A LCE1F LELP1 LCE4A LCE3E LCE3C LCE5A | 3.42e-21 | 203 | 22 | 13 | int:KRTAP5-9 |
| Interaction | KRTAP9-3 interactions | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A LCE3A LCE1F LCE4A LCE3E LCE3C LCE5A | 4.76e-21 | 140 | 22 | 12 | int:KRTAP9-3 |
| Interaction | KRTAP4-1 interactions | 6.56e-21 | 31 | 22 | 9 | int:KRTAP4-1 | |
| Interaction | KRTAP12-3 interactions | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A LCE3A LCE1F LCE4A LCE3E LCE3C LCE5A | 8.01e-21 | 146 | 22 | 12 | int:KRTAP12-3 |
| Interaction | KRTAP2-3 interactions | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A LCE3A LCE1F LCE3E LCE3C LCE5A | 9.49e-21 | 95 | 22 | 11 | int:KRTAP2-3 |
| Interaction | TRIM42 interactions | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A LCE3A LCE1F LCE4A LCE3E LCE3C LCE5A | 1.03e-20 | 149 | 22 | 12 | int:TRIM42 |
| Interaction | KRTAP10-1 interactions | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A LCE3A LCE1F LCE4A LCE3E LCE3C LCE5A | 1.43e-20 | 153 | 22 | 12 | int:KRTAP10-1 |
| Interaction | KRTAP2-4 interactions | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A LCE3A LCE1F LCE3E LCE3C LCE5A | 1.93e-20 | 101 | 22 | 11 | int:KRTAP2-4 |
| Interaction | LCE2A interactions | 7.01e-20 | 69 | 22 | 10 | int:LCE2A | |
| Interaction | RGS20 interactions | LCE3D LCE1B LCE1E LCE1D LCE1A LCE3A LCE1F LCE4A LCE3E LCE3C LCE5A | 1.15e-19 | 118 | 22 | 11 | int:RGS20 |
| Interaction | CHIC2 interactions | 1.28e-19 | 73 | 22 | 10 | int:CHIC2 | |
| Interaction | LCE4A interactions | 3.37e-19 | 80 | 22 | 10 | int:LCE4A | |
| Interaction | LCE2C interactions | 9.21e-19 | 88 | 22 | 10 | int:LCE2C | |
| Interaction | KRTAP10-6 interactions | 9.21e-19 | 88 | 22 | 10 | int:KRTAP10-6 | |
| Interaction | KRTAP12-4 interactions | 1.42e-18 | 53 | 22 | 9 | int:KRTAP12-4 | |
| Interaction | KRTAP10-9 interactions | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A LCE3A LCE1F LCE4A LCE3E LCE3C LCE5A | 3.78e-18 | 241 | 22 | 12 | int:KRTAP10-9 |
| Interaction | KRTAP1-3 interactions | LCE3D LCE1B LCE1E LCE1D LCE1A LCE3A LCE1F LCE4A LCE3E LCE3C LCE5A | 1.76e-17 | 184 | 22 | 11 | int:KRTAP1-3 |
| Interaction | KRTAP10-8 interactions | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A LCE3A LCE1F LELP1 LCE4A LCE3E LCE3C LCE5A | 2.67e-17 | 401 | 22 | 13 | int:KRTAP10-8 |
| Interaction | LCE1C interactions | 5.11e-17 | 77 | 22 | 9 | int:LCE1C | |
| Interaction | ADAMTSL4 interactions | LCE1C LCE3D LCE1B LCE1D LCE1A LCE3A LCE1F LCE4A LCE3E LCE3C LCE5A | 1.11e-16 | 217 | 22 | 11 | int:ADAMTSL4 |
| Interaction | LCE3B interactions | 1.21e-16 | 46 | 22 | 8 | int:LCE3B | |
| Interaction | KRTAP1-1 interactions | LCE3D LCE1B LCE1E LCE1D LCE1A LCE3A LCE1F LCE4A LCE3E LCE3C LCE5A | 1.23e-16 | 219 | 22 | 11 | int:KRTAP1-1 |
| Interaction | LCE1B interactions | 1.30e-16 | 85 | 22 | 9 | int:LCE1B | |
| Interaction | LCE5A interactions | 2.22e-16 | 90 | 22 | 9 | int:LCE5A | |
| Interaction | NBPF19 interactions | LCE3D LCE1B LCE1E LCE1D LCE1A LCE3A LCE1F LCE4A LCE3E LCE3C LCE5A | 2.46e-16 | 233 | 22 | 11 | int:NBPF19 |
| Interaction | LCE1F interactions | 2.73e-16 | 92 | 22 | 9 | int:LCE1F | |
| Interaction | KRTAP6-3 interactions | 4.75e-16 | 161 | 22 | 10 | int:KRTAP6-3 | |
| Interaction | VWC2 interactions | 1.55e-15 | 62 | 22 | 8 | int:VWC2 | |
| Interaction | KRTAP10-7 interactions | LCE3D LCE1B LCE1E LCE1D LCE1A LCE3A LCE1F LCE4A LCE3E LCE3C LCE5A | 3.11e-15 | 293 | 22 | 11 | int:KRTAP10-7 |
| Interaction | LCE1E interactions | 3.38e-15 | 68 | 22 | 8 | int:LCE1E | |
| Interaction | KRTAP5-7 interactions | 4.86e-15 | 71 | 22 | 8 | int:KRTAP5-7 | |
| Interaction | KRTAP3-2 interactions | 1.18e-14 | 79 | 22 | 8 | int:KRTAP3-2 | |
| Interaction | SMCP interactions | 1.18e-14 | 79 | 22 | 8 | int:SMCP | |
| Interaction | LCE1A interactions | 1.97e-14 | 84 | 22 | 8 | int:LCE1A | |
| Interaction | HOXA1 interactions | LCE1C LCE3D LCE1B LCE1D LCE1A LCE3A LCE1F LCE4A LCE3E LCE3C LCE5A | 2.66e-14 | 356 | 22 | 11 | int:HOXA1 |
| Interaction | CYSRT1 interactions | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A LCE3A LCE1F LCE4A LCE3E LCE3C LCE5A | 3.19e-14 | 511 | 22 | 12 | int:CYSRT1 |
| Interaction | NOTCH2NLA interactions | LCE3D LCE1B LCE1E LCE1D LCE1A LCE3A LCE1F LCE4A LCE3E LCE3C LCE5A | 5.59e-14 | 381 | 22 | 11 | int:NOTCH2NLA |
| Interaction | MACO1 interactions | 1.03e-13 | 175 | 22 | 9 | int:MACO1 | |
| Interaction | KRTAP12-1 interactions | 3.40e-13 | 63 | 22 | 7 | int:KRTAP12-1 | |
| Interaction | LCE1D interactions | 7.33e-13 | 70 | 22 | 7 | int:LCE1D | |
| Interaction | SPRY3 interactions | 1.28e-12 | 35 | 22 | 6 | int:SPRY3 | |
| Interaction | VASN interactions | 3.85e-12 | 160 | 22 | 8 | int:VASN | |
| Interaction | KRTAP17-1 interactions | 9.57e-12 | 48 | 22 | 6 | int:KRTAP17-1 | |
| Interaction | FBLN1 interactions | 5.88e-11 | 129 | 22 | 7 | int:FBLN1 | |
| Interaction | CRCT1 interactions | 7.00e-11 | 66 | 22 | 6 | int:CRCT1 | |
| Interaction | KRTAP10-10 interactions | 7.56e-11 | 27 | 22 | 5 | int:KRTAP10-10 | |
| Interaction | LCE3C interactions | 7.68e-11 | 67 | 22 | 6 | int:LCE3C | |
| Interaction | EFEMP2 interactions | 8.55e-11 | 136 | 22 | 7 | int:EFEMP2 | |
| Interaction | SPRY2 interactions | 1.87e-10 | 152 | 22 | 7 | int:SPRY2 | |
| Interaction | CYP21A2 interactions | 2.21e-10 | 33 | 22 | 5 | int:CYP21A2 | |
| Interaction | KRTAP3-3 interactions | 2.67e-10 | 82 | 22 | 6 | int:KRTAP3-3 | |
| Interaction | MDFI interactions | 3.28e-10 | 430 | 22 | 9 | int:MDFI | |
| Interaction | GRN interactions | 3.49e-10 | 281 | 22 | 8 | int:GRN | |
| Interaction | VWC2L interactions | 6.11e-10 | 40 | 22 | 5 | int:VWC2L | |
| Interaction | PLSCR2 interactions | 1.92e-09 | 16 | 22 | 4 | int:PLSCR2 | |
| Interaction | TSPAN4 interactions | 2.64e-09 | 53 | 22 | 5 | int:TSPAN4 | |
| Interaction | KRTAP12-2 interactions | 4.00e-09 | 128 | 22 | 6 | int:KRTAP12-2 | |
| Interaction | KRTAP3-1 interactions | 2.95e-08 | 85 | 22 | 5 | int:KRTAP3-1 | |
| Interaction | TGFB1 interactions | 3.11e-08 | 317 | 22 | 7 | int:TGFB1 | |
| Interaction | SLC39A7 interactions | 3.88e-08 | 187 | 22 | 6 | int:SLC39A7 | |
| Interaction | KRTAP9-4 interactions | 4.27e-08 | 33 | 22 | 4 | int:KRTAP9-4 | |
| Interaction | KRTAP5-8 interactions | 6.30e-08 | 8 | 22 | 3 | int:KRTAP5-8 | |
| Interaction | KRTAP11-1 interactions | 9.86e-08 | 108 | 22 | 5 | int:KRTAP11-1 | |
| Interaction | PCSK5 interactions | 1.18e-07 | 112 | 22 | 5 | int:PCSK5 | |
| Interaction | PLA2G10 interactions | 1.24e-07 | 113 | 22 | 5 | int:PLA2G10 | |
| Interaction | FUCA2 interactions | 1.28e-07 | 43 | 22 | 4 | int:FUCA2 | |
| Interaction | CATSPER1 interactions | 2.13e-07 | 126 | 22 | 5 | int:CATSPER1 | |
| Interaction | PLAC8 interactions | 3.25e-06 | 27 | 22 | 3 | int:PLAC8 | |
| Interaction | NUFIP2 interactions | 4.27e-06 | 417 | 22 | 6 | int:NUFIP2 | |
| Interaction | PLSCR3 interactions | 1.89e-05 | 48 | 22 | 3 | int:PLSCR3 | |
| Interaction | OTX1 interactions | 2.21e-05 | 155 | 22 | 4 | int:OTX1 | |
| Interaction | NECTIN2 interactions | 2.44e-05 | 159 | 22 | 4 | int:NECTIN2 | |
| Interaction | CREB5 interactions | 2.76e-05 | 164 | 22 | 4 | int:CREB5 | |
| Interaction | SPPL3 interactions | 2.96e-05 | 886 | 22 | 7 | int:SPPL3 | |
| Interaction | OIT3 interactions | 4.72e-05 | 65 | 22 | 3 | int:OIT3 | |
| Interaction | PLSCR4 interactions | 7.25e-05 | 75 | 22 | 3 | int:PLSCR4 | |
| Interaction | LCE3A interactions | 7.54e-05 | 76 | 22 | 3 | int:LCE3A | |
| Interaction | NTAQ1 interactions | 8.52e-05 | 431 | 22 | 5 | int:NTAQ1 | |
| Interaction | POU4F2 interactions | 9.80e-05 | 83 | 22 | 3 | int:POU4F2 | |
| Interaction | TGM1 interactions | 9.94e-05 | 228 | 22 | 4 | int:TGM1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A SPRR2D SPRR2F LCE3A LCE1F LELP1 LCE4A LCE3E LCE3C LCE5A | 1.83e-26 | 404 | 22 | 15 | chr1q21 |
| Cytoband | 1q21.3 | LCE1C LCE1B LCE1E LCE1D LCE1A LCE3A LCE1F LELP1 LCE4A LCE3E LCE3C LCE5A | 2.66e-26 | 117 | 22 | 12 | 1q21.3 |
| Cytoband | 1q21-q22 | 5.51e-05 | 23 | 22 | 2 | 1q21-q22 | |
| GeneFamily | Late cornified envelope proteins | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A LCE3A LCE1F LCE4A LCE3E LCE3C LCE5A | 3.68e-34 | 18 | 19 | 12 | 627 |
| GeneFamily | Small proline rich proteins | 5.72e-05 | 11 | 19 | 2 | 1353 | |
| GeneFamily | SH2 domain containing | 4.97e-03 | 101 | 19 | 2 | 741 | |
| Coexpression | JARDIM_PERASSI_TRIPLE_NEGATIVE_BREAST_CANCER_MOUSE_XENOGRAFT_MELATONIN_UP | 1.65e-12 | 49 | 21 | 6 | MM452 | |
| Coexpression | HOLLERN_SQUAMOUS_BREAST_TUMOR | 1.65e-10 | 204 | 21 | 7 | MM966 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_UP | 7.10e-07 | 689 | 21 | 7 | MM1041 | |
| Coexpression | MARTINEZ_TP53_TARGETS_UP | 7.45e-07 | 694 | 21 | 7 | MM1039 | |
| Coexpression | MARTINEZ_RB1_TARGETS_DN | 7.51e-06 | 630 | 21 | 6 | MM1038 | |
| Coexpression | DARWICHE_SKIN_TUMOR_PROMOTER_UP | 2.40e-04 | 153 | 21 | 3 | MM495 | |
| Coexpression | DARWICHE_PAPILLOMA_RISK_HIGH_UP | 3.56e-04 | 175 | 21 | 3 | MM499 | |
| Coexpression | DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP | 3.56e-04 | 175 | 21 | 3 | MM501 | |
| Coexpression | DARWICHE_PAPILLOMA_RISK_LOW_UP | 4.67e-04 | 192 | 21 | 3 | MM497 | |
| Coexpression | BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_DN | 6.67e-04 | 217 | 21 | 3 | M34023 | |
| CoexpressionAtlas | skin | LCE1C LCE3D LCE1B LCE1E LCE1D LCE1A LCE1F LGI3 LCE4A LCE3E LCE5A | 2.27e-13 | 456 | 22 | 11 | skin |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_250 | 5.08e-08 | 206 | 22 | 6 | Facebase_ST1_Univ_250 | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_500 | 1.66e-07 | 427 | 22 | 7 | Facebase_ST1_Univ_500 | |
| CoexpressionAtlas | tonsil | 1.02e-06 | 182 | 22 | 5 | tonsil | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_500_3 | 8.11e-05 | 82 | 22 | 3 | Facebase_ST1_Univ_500_3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.11e-04 | 142 | 22 | 3 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k1 | |
| ToppCell | TCGA-Skin-Primary_Tumor|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.46e-12 | 190 | 22 | 7 | e2b26a03c6ab24d9b0f4150c47597be37767d86e | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.46e-12 | 190 | 22 | 7 | 3188c7bd225cbcf46a21e2fb784336cdd9665995 | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.46e-12 | 190 | 22 | 7 | 01fb45add4661bc86cd0a34fac35177907152dbb | |
| ToppCell | TCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Non-Seminoma-_Embryonal_Carcinoma,_Immature_Teratoma,_Mature_Teratoma,_Yolk_Sac_Tumor-3|TCGA-Testes / Sample_Type by Project: Shred V9 | 2.93e-11 | 125 | 22 | 6 | 5f90de494b53ecce6455034f3ed5dccdbb2c29ca | |
| ToppCell | TCGA-Head_and_Esophagus|World / Sample_Type by Project: Shred V9 | 1.92e-08 | 172 | 22 | 5 | eb18aa179db1818f408c38e442ecfed8582d7dbc | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Metaplastic_Carcinoma-2|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.16e-07 | 92 | 22 | 4 | cad8b1b74a412988b2ae4f6126b2186100a2cdc2 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_2|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.97e-07 | 132 | 22 | 4 | 780a391924f776dc6fbe44ddcf4ae0583a1e2157 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.44e-07 | 135 | 22 | 4 | 366a417f9ef7c0d86e9f262d97bf788f478315ee | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.85e-07 | 143 | 22 | 4 | 6df16bf0324661cd9707df69cb39f4b5498d6d49 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 9.69e-07 | 156 | 22 | 4 | ffb9249a115ce31f50b99a7a3d40bf48b9d7f2b0 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.18e-06 | 164 | 22 | 4 | de1646dbcf2a10b48e021acf7dc63e803e6a47ce | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-06 | 173 | 22 | 4 | 0f9c1d3298e59e6d22bb3306f0f445f490be8bbd | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Metaplastic_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 5.68e-06 | 71 | 22 | 3 | ab476ee0b91d91d44d4324da18e2e7938bba3d2c | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-8|TCGA-Kidney / Sample_Type by Project: Shred V9 | 2.96e-05 | 123 | 22 | 3 | 967f20fcb27c9989de93f4183038334105910175 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-05 | 147 | 22 | 3 | 9d7e965fe61bd7b31e09c4b2129a5a98c36f4811 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-05 | 147 | 22 | 3 | 38552953ff65a0fc20bee6ef57dc5885306ad18b | |
| ToppCell | TCGA-Stomach-Solid_Tissue_Normal-Stomach_normal_tissue-Stomach_normal_tissue-4|TCGA-Stomach / Sample_Type by Project: Shred V9 | 6.11e-05 | 157 | 22 | 3 | 2553ebf3e48de5bd184e77bd61114faa5a1d95ed | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-6|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 7.74e-05 | 170 | 22 | 3 | 3dba3f810fbd1eadf446b52e4c9c971d362a80e1 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-suprabasal_interpapillary|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.01e-05 | 172 | 22 | 3 | 6ece9bb9f31685c918ca4cb7b82cf6ad1cad48af | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.02e-05 | 179 | 22 | 3 | 2b5f8e109a67c7fc3ec2b83e8f1854160c99283a | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-suprabasal_interpapillary|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.17e-05 | 180 | 22 | 3 | 18bf8561ad3aa9787d2a8ef942a96f641734c608 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.11e-04 | 192 | 22 | 3 | 24fb2f1e6f49ab5b71876e105c0ee7f59e7d64e8 | |
| ToppCell | NS-moderate-d_07-13|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.16e-04 | 195 | 22 | 3 | 088209505a68519ec89f50f0576096da6966bf17 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Basal_2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.22e-04 | 198 | 22 | 3 | 686eda427b075e788de38149eae82faf19bd5704 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.22e-04 | 198 | 22 | 3 | 34997e3896d0893fbe51bfb0d4660ccaca1c975e | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.22e-04 | 198 | 22 | 3 | a54ae5275a510b49d7629f0908817a0c5f05020e | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Squamous|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.22e-04 | 198 | 22 | 3 | b7495369baba203490c067a58fc8456a778a12e4 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Adora2a-Excitatory_Neuron.Gad1Gad2.Adora2a-Nnat_(iSPN)|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.22e-04 | 54 | 22 | 2 | d21611ae38d34d62f855fa3797eb37a5d287a4a5 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Adora2a-Excitatory_Neuron.Gad1Gad2.Adora2a-Nnat_(iSPN)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.22e-04 | 54 | 22 | 2 | 20309afadc500f1485e86c62d8d38168c9253539 | |
| Drug | beta-damascenone | 6.86e-09 | 24 | 22 | 4 | ctd:C075388 | |
| Disease | vitamin D measurement | 4.65e-11 | 336 | 21 | 8 | EFO_0004631 | |
| Disease | atopic eczema | 3.20e-10 | 252 | 21 | 7 | EFO_0000274 | |
| Disease | hair morphology | 1.12e-06 | 29 | 21 | 3 | EFO_0005038 | |
| Disease | Psoriasis | 8.87e-06 | 57 | 21 | 3 | C0033860 | |
| Disease | Pustulosis of Palms and Soles | 8.87e-06 | 57 | 21 | 3 | C0030246 | |
| Disease | psoriasis | 3.79e-05 | 273 | 21 | 4 | EFO_0000676 | |
| Disease | childhood onset asthma | 8.29e-05 | 334 | 21 | 4 | MONDO_0005405 | |
| Disease | sleep latency | 3.16e-04 | 37 | 21 | 2 | EFO_0005280 | |
| Disease | atopic asthma | 3.67e-04 | 199 | 21 | 3 | EFO_0010638 | |
| Disease | asthma | 1.76e-03 | 751 | 21 | 4 | MONDO_0004979 | |
| Disease | memory performance | 2.92e-03 | 409 | 21 | 3 | EFO_0004874 | |
| Disease | Organic Mental Disorders, Substance-Induced | 3.01e-03 | 115 | 21 | 2 | C0029231 | |
| Disease | Drug Use Disorders | 3.01e-03 | 115 | 21 | 2 | C0013222 | |
| Disease | Drug Dependence | 3.01e-03 | 115 | 21 | 2 | C1510472 | |
| Disease | Drug habituation | 3.01e-03 | 115 | 21 | 2 | C0013170 | |
| Disease | Substance Dependence | 3.01e-03 | 115 | 21 | 2 | C0038580 | |
| Disease | Substance Use Disorders | 3.01e-03 | 115 | 21 | 2 | C0038586 | |
| Disease | Substance-Related Disorders | 3.01e-03 | 115 | 21 | 2 | C0236969 | |
| Disease | Prescription Drug Abuse | 3.01e-03 | 115 | 21 | 2 | C4316881 | |
| Disease | Drug abuse | 3.01e-03 | 115 | 21 | 2 | C0013146 | |
| Disease | Substance abuse problem | 3.06e-03 | 116 | 21 | 2 | C0740858 | |
| Disease | emphysema imaging measurement | 4.80e-03 | 146 | 21 | 2 | EFO_0007626 | |
| Disease | autoimmune disease | 6.67e-03 | 173 | 21 | 2 | EFO_0005140 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PPPDQPSPCKCTCKK | 521 | P43681 | |
| KGKPPTCKPVACPSI | 2546 | Q96PZ7 | |
| DSQLCPKPPPKPCKV | 396 | O75815 | |
| KCPWEKCPAPPKCLP | 46 | Q5T871 | |
| KCPAPPKCLPCPSQS | 51 | Q5T871 | |
| PQPCTKPCPPKCPSS | 71 | Q5T871 | |
| KPCPPKCPSSCPHAC | 76 | Q5T871 | |
| PKCPPKCPPVSSCCS | 31 | Q5T7P2 | |
| CIPKCPPKCLTPRCP | 16 | Q5T7P3 | |
| PKCPPKCPPVSSCCS | 31 | Q5T7P3 | |
| PKCPPKCPPVSSCCS | 31 | Q5T751 | |
| CTPKCTPKCPAPKCP | 16 | Q5T752 | |
| APKCPPKCPPVSSCC | 26 | Q5T752 | |
| PKCPPKCPPVSSCCS | 31 | Q5T753 | |
| PKCPPKCPPVSSCCS | 31 | Q5T754 | |
| QPPPKCPAKSPAQCL | 11 | Q5TA76 | |
| CPSPKCPPKSPAQCL | 16 | Q5T5A8 | |
| CPSPKCPPKSPVQCL | 16 | Q9BYE3 | |
| CPSPKCPPKNPVQCL | 16 | Q5T5B0 | |
| CPIPKYPPKCPSKCA | 16 | Q5TA78 | |
| YPPKCPSKCASSCPP | 21 | Q5TA78 | |
| KCPPKCPPQCSAPCP | 31 | Q5TCM9 | |
| CQKKPCPPALCPHPS | 876 | Q6ZWJ8 | |
| KCPEPCPSPKCPQPC | 31 | P22532 | |
| KCPEPCPPSKCPQSC | 31 | Q96RM1 | |
| SPACLPPPPKKTCTN | 126 | O95789 | |
| PPPPKKTCTNCSKDI | 131 | O95789 | |
| PSDAVKPCPCVPKPV | 651 | Q9UKW4 | |
| KRPPKTPPCPPSCSC | 31 | Q8N145 |